AI MARKET SCANNING

Vaxart Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -1.71%
MAX GAP RECORD +9.76%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $VXRT
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
+0.00%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
+0.00%
Mar 12, 2026 Earnings Release 2026-03-12 (AFTER CLOSE)
-1.35%
Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE)
+0.00%
Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE)
-2.70%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
+0.00%
Mar 20, 2025 Earnings Release 2025-03-20 (AFTER CLOSE)
-5.26%
Nov 13, 2024 Earnings Release 2024-11-13 (AFTER CLOSE)
-2.82%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.8%
Bullish Gaps (1)
Bearish Gaps (8)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $VXRT

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗